Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 1
A Phase 1 Study to Evaluate the Safety of a Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea
While the pathophysiology of diarrhea-predominant irritable bowel syndrome (IBS-D) is complex and heterogeneous, dysbiosis of the gut microbiome is frequently …
IBS (Irritable Bowel Syndrome)Diarrhea
Estimated
~$10 – $6,250
Stanford UniversityNCT07238790
Phase 2
A Phase 2b, Randomized, Double-Blind, Placebo- Controlled, Multicenter Study to Assess the Safety, Efficacy and Pharmacokinetics of RNIB21 in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
The purpose of this study is to examine the effectiveness of using a combination of a drug, rifaximin and a dietary supplement, N-acetyl-L-cysteine (NAC), to t…
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)
Estimated
~$10 – $7,500
Mark Pimentel, MDNCT06727422